Wednesday, 21 April 2021
No Result
View All Result
eudebates.tv
  • EU Policies
  • World
  • Special Debates
  • Events
  • Vote & Polls
eudebates.tv
No Result
View All Result
Home Debates EU Policies Health

EMA investigates AstraZeneca Vaccine and thromboembolic events

EUdebates Team by EUdebates Team
16/03/2021
in Health
Reading Time: 3 mins read
0
18
SHARES
179
VIEWS
Share on FacebookShare on Twitter

Join EU debates

Health: Keep mothers and newborns together

World Health Day: Stella Kyriakides EU debates Health Union

India donates 200,000 vaccine doses to UN blue helmets peacekeepers

President von der Leyen looks to speed up vaccine rollout

Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 AstraZeneca vaccine. This is a precaution taken in the light of their national situation while European Medicines Agency (EMA) investigates a number of events of blood clots in people who had received the vaccine, as previously reported.

Events involving blood clots, some with unusual features such as low numbers of platelets, have occurred in a very small number of people who received the vaccine. Many thousands of people develop blood clots annually in the EU for different reasons. The number of thromboembolic events overall in vaccinated people seems not to be higher than that seen in the general population.

European Medicines Agency (EMA) is working closely with the company, with experts in blood disorders, and with other health authorities including the UK’s MHRA based on its experience with around 11 million administered doses of the vaccine.

WHO and European Medicines Agency investigate AstraZeneca vaccines

Exterior of European Medicines Agency in Amsterdam - EMA

EMA’s investigation has been continuing over the weekend, and rigorous analysis of all the data related to thromboembolic events will be carried out in the coming days. Experts are looking in great detail at all the available data and clinical circumstances surrounding specific cases to determine whether the vaccine might have contributed or if the event is likely to have been due to other causes. EMA’s safety committee (PRAC) will further review the information tomorrow (Tuesday) and has called an extraordinary meeting on Thursday 18 March to conclude on the information gathered and any further actions that may need to be taken.

The COVID-19 pandemic is a global crisis, with devastating health, social and economic impact, and continues to be a major burden on EU health systems. Vaccines for COVID-19 help to protect individuals from becoming ill, especially healthcare professionals and vulnerable populations, such as older people or those with chronic diseases. While its investigation is ongoing, European Medicines Agency (EMA) currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects.

European Medicines Agency (EMA) will continue to communicate further as appropriate. In the meantime, anyone who has received the vaccine and has any concerns should contact an appropriate healthcare professional. It is important that people who suspect they may have a side effect after vaccination report this to the national medicines regulator, or to a healthcare professional who can help them do so.

More about the AstraZeneca vaccine

AstraZeneca vaccine is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older. COVID-19 is caused by SARS-CoV-2 virus. COVID-19 AstraZeneca vaccine is made up of another virus (of the adenovirus family) that has been modified to contain the gene for making a protein from SARS-CoV-2. AstraZeneca vaccine does not contain the virus itself and cannot cause COVID-19.

The most common side effects with COVID-19 AstraZeneca vaccine are usually mild or moderate and improve within a few days after vaccination.

More about the procedure

The review of thromboembolic events with COVID-19 AstraZeneca vaccine is being carried out in the context of a safety signal, under an accelerated timetable. A safety signal is information on a new or incompletely documented adverse event that is potentially caused by a medicine such as a vaccine and that warrants further investigation.

The review is being carried out by EMA‘s Pharmacovigilance Risk Assessment Committee (PRAC), the Committee responsible for the evaluation of safety issues for human medicines. Once the review is completed, PRAC will make any recommendations necessary to minimise risks and protect patients’ health.

eudebates AstraZeneca vaccine

Share this debate with your friends!
Follow #eudebates on Google News and on Facebook
Tags: EU Health Security CommitteeEuropean Climate and Health ObservatoryEuropean Health UnionEuropean Medicines Agency (EMA)HealthcareHuman HealthPublic Healththe Future of MedicineVaccinationVaccinationsVaccinesWHOWorld Health Organisation
Share7Tweet5

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe

Related EU debates

small-baby mother newborn
Health

Health: Keep mothers and newborns together

16/04/2021
Stella Kyriakides, European Commissioner for Health and Food Safety
Health

World Health Day: Stella Kyriakides EU debates Health Union

06/04/2021
India donates 200,000 vaccines to protect UN blue helmets against COVID
Health

India donates 200,000 vaccine doses to UN blue helmets peacekeepers

29/03/2021
Ursula von der Leyen President of the European Commission
Health

President von der Leyen looks to speed up vaccine rollout

17/03/2021
The label of the empty vial is crossed out to prevent further fraud and thrown into a specific container
Health

WHO: Do not STOP vaccinations of AstraZeneca Vaccine

16/03/2021
A shipment of Astrazeneca Covid-19 is received and checked in Coimbra
Health

WHO and European Medicines Agency investigate AstraZeneca vaccine

16/03/2021

Leave a Reply Cancel reply

Your email address will not be published.

Maroš Šefčovič, Vice-President of the European Commission in charge of Interinstitutional relations and Foresight

Šefčovič hold ‘productive’ talks with Lord Frost on Northern Ireland crisis

19/04/2021
Mr Charles MICHEL, President of the European Council; Mr Volodymyr ZELENSKYY, President of Ukraine

President Michel promises support to Ukraine President Zelenskyy

16/04/2021
small-baby mother newborn

Health: Keep mothers and newborns together

16/04/2021
Halloumi cheese from Cyprus

Halloumi Cyprus cheese joins EU PDO – Protected designation of origin

12/04/2021
Europol building

EU serious and organised crime threat assessment (SOCTA) 2021

12/04/2021
eye-controls AI Artificial Intelligence Technology

AI technologies must prevent discrimination and protect diversity

11/04/2021
  • Nigel Farage

    EU nasty and vindictive? Nigel Farage criticizes EU vaccines strategy

    78 shares
    Share 31 Tweet 20
  • EU: AstraZeneca logic can only work at the neighbourhood butchers

    54 shares
    Share 22 Tweet 14
  • EU Health Emergency Preparedness and Response Authority (HERA)

    49 shares
    Share 20 Tweet 12
  • Why don’t we print money for Corona Crisis?

    113 shares
    Share 114 Tweet 72
  • After Brexit will the UK lose the Falkland Islands?

    42 shares
    Share 17 Tweet 11

Join eudebates newsletter!

Enter your email to receive our newsletter.

Don't worry, we don't spam
eudebates.tv

Welcome to eudebates.tv the unique european initiative to promote debate, dialogue and communication among citizens for a better Europe.

Follow us on social media:

Recent News

  • Šefčovič hold ‘productive’ talks with Lord Frost on Northern Ireland crisis
  • President Michel promises support to Ukraine President Zelenskyy
  • Health: Keep mothers and newborns together
  • Halloumi Cyprus cheese joins EU PDO – Protected designation of origin
  • EU serious and organised crime threat assessment (SOCTA) 2021

Newsletter

Join eudebates newsletter!

Enter your email to receive our newsletter.

Don't worry, we don't spam
Maroš Šefčovič, Vice-President of the European Commission in charge of Interinstitutional relations and Foresight

Šefčovič hold ‘productive’ talks with Lord Frost on Northern Ireland crisis

19/04/2021
Mr Charles MICHEL, President of the European Council; Mr Volodymyr ZELENSKYY, President of Ukraine

President Michel promises support to Ukraine President Zelenskyy

16/04/2021
small-baby mother newborn

Health: Keep mothers and newborns together

16/04/2021
  • Home
  • EU Policies
  • Special Debates
  • Events
  • Vote & Polls
  • Video

© 2021 eudebates - EU debates, dialogue, communication for a better Europe - Privacy Policy.

No Result
View All Result
  • EU Policies
  • World
  • Special Debates
  • Events
  • Vote & Polls

© 2021 eudebates - EU debates, dialogue, communication for a better Europe - Privacy Policy.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In